FAS Statement on Michael Kratsios’ OSTP Hearing
Yesterday, Michael Kratsios, the president’s nominee to be director of the White House Office of Science and Technology Policy (OSTP), repeatedly stressed his belief in the importance of continuing the United States’ historic leadership in science and technological innovation, and the goal of “ensuring that all Americans benefit from scientific and technological advances.”
Mr. Kratsios’ words, along with his track record and OSTP experience as U.S. Chief Technology Officer, offer encouragement that our community can continue to work constructively with him and the important office he would lead.
With so much at stake, we cannot afford to cede science and technological leadership or its underpinnings: foundational federal R&D investments, growing STEM talent pipelines, and the best scientific and technical expertise to support policymakers. Commitment to these things are the basis for a healthy and thriving society.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.
Inconsistent metrics and opaque reporting make future AI power‑demand estimates extremely uncertain, leaving grid planners in the dark and climate targets on the line